BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10403635)

  • 1. Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicology; 1999 Jun; 134(2-3):169-78. PubMed ID: 10403635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eptastigmine-phosphotriesterase combination in DFP intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):364-9. PubMed ID: 8887453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):555-60. PubMed ID: 8975781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice against soman by pretreatment with eptastigmine and physostigmine.
    Tuovinen K; Hänninen O
    Toxicology; 1999 Dec; 139(3):233-41. PubMed ID: 10647923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.
    Deshpande SS; Viana GB; Kauffman FC; Rickett DL; Albuquerque EX
    Fundam Appl Toxicol; 1986 Apr; 6(3):566-77. PubMed ID: 3699340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antidotes and their combinations in the treatment of acute carbamate poisoning in rats.
    Stojiljković MP; Škrbić R; Jokanović M; Kilibarda V; Bokonjić D; Vulović M
    Toxicology; 2018 Sep; 408():113-124. PubMed ID: 30176331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.
    Galli A; Mori F
    Arch Toxicol; 1991; 65(4):330-4. PubMed ID: 1953352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the efficacy of HI6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit.
    Koplovitz I; Stewart JR
    Toxicol Lett; 1994 Feb; 70(3):269-79. PubMed ID: 8284794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against Soman poisoning in vivo.
    Xia DY; Wang LX; Pei SQ
    Fundam Appl Toxicol; 1981; 1(2):217-21. PubMed ID: 7184786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies.
    Braida D; Sala M
    CNS Drug Rev; 2001; 7(4):369-86. PubMed ID: 11830755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection from quinidine or physostigmine against in vitro inhibition by sarin of acetylcholinesterase activity.
    Singh AK; Zeleznikar RJ; Drewes LR
    Life Sci; 1986 Jan; 38(2):165-72. PubMed ID: 3945161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig.
    Wetherell J; Hall T; Passingham S
    Neurotoxicology; 2002 Sep; 23(3):341-9. PubMed ID: 12387361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostigmine.
    Bansal I; Waghmare CK; Anand T; Gupta AK; Bhattacharya BK
    J Appl Toxicol; 2009 Jul; 29(5):386-94. PubMed ID: 19283689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of poisoning by soman.
    Leadbeater L; Inns RH; Rylands JM
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S225-31. PubMed ID: 4092890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine.
    Harris L; Stitcher D
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):64-9. PubMed ID: 6493352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.
    Albuquerque EX; Pereira EF; Aracava Y; Fawcett WP; Oliveira M; Randall WR; Hamilton TA; Kan RK; Romano JA; Adler M
    Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13220-5. PubMed ID: 16914529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of organophosphate-inactivated esterases with phosphotriesterase.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Fundam Appl Toxicol; 1996 Jun; 31(2):210-7. PubMed ID: 8789787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A symptomatological assessment of organophosphate-induced lethality in mice: comparison of atropine and clonidine protection.
    Liu WF
    Toxicol Lett; 1991 Apr; 56(1-2):19-32. PubMed ID: 2017778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication.
    Bueters TJ; Groen B; Danhof M; IJzerman AP; Van Helden HP
    Arch Toxicol; 2002 Nov; 76(11):650-6. PubMed ID: 12415428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.